When should therapeutic drug trough levels be drawn?

When to Draw Therapeutic Drug Trough Levels

Draw trough levels just before the fourth dose at steady-state conditions, which occurs approximately 10-12 hours after the last dose for most drugs. 1

Timing Principles

The timing of trough level collection is critical for accurate therapeutic drug monitoring and varies by drug class:

Vancomycin

• Obtain trough levels just before the fourth dose when steady-state is typically achieved 1
• Draw within 30 minutes before the next scheduled dose 2
• For serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia), all patients on prolonged courses should have at least one steady-state trough measured 1
• Do not routinely monitor for short courses (≤5 days) or lower-intensity dosing targeting troughs ≤15 mg/L 1
• For critically ill patients requiring aggressive dosing (target trough 15-20 mg/L), monitor more frequently, especially those with renal dysfunction, obesity, or fluctuating volumes of distribution 3, 1

Aminoglycosides (Gentamicin, Amikacin)

• Trough: Draw predose to ensure levels remain <5 mg/L (gentamicin) or <1 mg/L to minimize nephrotoxicity 4, 2
• Peak: Draw 90-120 minutes after infusion ends (or 60 minutes as alternative), then extrapolate back to time=0 for true peak 4
• For once-daily dosing regimens, monitoring primarily focuses on ensuring adequately low troughs rather than peaks 2
• Initial peak levels should be obtained in the first week; trough levels weekly for 4 weeks, then can reduce to fortnightly when stable 4

Pediatric Considerations

• Gentamicin for synergy: Target peak 3-4 μg/mL, trough <1 μg/mL using every 8-hour dosing 5
• Vancomycin: Target trough 10-15 μg/mL (may need 15-20 μg/mL for resistant organisms with MIC >1 μg/mL); monitor only trough concentrations 5

Key Timing Pitfalls to Avoid

Common errors that invalidate results:

1. Drawing levels too early is extremely common—43% of vancomycin troughs in one study were mistimed 6

   • Early troughs ≥10 mg/L measured >2 hours early with CrCl ≥60 mL/min can differ by ≥2 mg/L from true trough 6
   • This leads to falsely elevated results and potential underdosing

2. Drawing during absorption phase (within 10-12 hours of oral dosing) produces unpredictable, artificially elevated concentrations that don't reflect average steady-state levels 7

3. Not waiting for steady-state (typically 5× the drug's half-life, or approximately before the fourth dose for drugs with 24-hour half-lives) 7

When NOT to Draw Levels

• Peak vancomycin concentrations are not recommended for monitoring efficacy or reducing nephrotoxicity 1, 3, 1
• Short vancomycin courses ≤5 days with lower target troughs do not require routine monitoring 1
• Patients with normal renal function receiving standard vancomycin doses (1g every 12h) for uncomplicated skin infections typically don't require trough monitoring 3

Documentation Requirements

For proper interpretation, always document these three variables when ordering or recording TDM results 7:

1. Exact dose the patient is taking
2. Time interval between last dose and sample collection (ideally 10-12 hours for oral drugs)
3. Confirmation of steady-state (typically after 4-5 doses at consistent intervals)

Without this information, TDM results cannot be optimally interpreted and may lead to inappropriate dosing adjustments 7.